These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27285732)

  • 1. Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7.
    Abozeid SM; Hathout RM; Abou-Aisha K
    Colloids Surf B Biointerfaces; 2016 Sep; 145():607-616. PubMed ID: 27285732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease.
    Attarwala H; Clausen V; Chaturvedi P; Amiji MM
    Mol Pharm; 2017 Sep; 14(9):3036-3044. PubMed ID: 28737923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells.
    Liu L; Li H; Zhang M; Lv X
    Int J Clin Exp Pathol; 2015; 8(6):6674-82. PubMed ID: 26261549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
    Ofokansi K; Winter G; Fricker G; Coester C
    Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy.
    Cheng WJ; Chen LC; Ho HO; Lin HL; Sheu MT
    Int J Nanomedicine; 2018; 13():7079-7094. PubMed ID: 30464460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly(amidoamine) for siRNA delivery.
    Chen CJ; Wang JC; Zhao EY; Gao LY; Feng Q; Liu XY; Zhao ZX; Ma XF; Hou WJ; Zhang LR; Lu WL; Zhang Q
    Biomaterials; 2013 Jul; 34(21):5303-16. PubMed ID: 23570718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy.
    Qian J; Xu M; Suo A; Xu W; Liu T; Liu X; Yao Y; Wang H
    Acta Biomater; 2015 Mar; 15():102-16. PubMed ID: 25545322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing.
    Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT
    Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
    Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
    Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of siRNA-loaded polyethylenimine-coated human serum albumin nanoparticle complexes for the treatment of breast cancer.
    Abbasi S; Paul A; Prakash S
    Cell Biochem Biophys; 2011 Nov; 61(2):277-87. PubMed ID: 21556941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
    Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
    Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer.
    Han J; Wang Q; Zhang Z; Gong T; Sun X
    Small; 2014 Feb; 10(3):524-35. PubMed ID: 24106138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer.
    Powell D; Chandra S; Dodson K; Shaheen F; Wiltz K; Ireland S; Syed M; Dash S; Wiese T; Mandal T; Kundu A
    Eur J Pharm Biopharm; 2017 May; 114():108-118. PubMed ID: 28131717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro.
    Yang L; Tian Y; Leong WS; Song H; Yang W; Wang M; Wang X; Kong J; Shan B; Song Z
    Breast Cancer Res; 2018 Sep; 20(1):113. PubMed ID: 30227879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.
    Benfer M; Kissel T
    Eur J Pharm Biopharm; 2012 Feb; 80(2):247-56. PubMed ID: 22085653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles.
    Ladewig K; Niebert M; Xu ZP; Gray PP; Lu GQ
    Biomaterials; 2010 Mar; 31(7):1821-9. PubMed ID: 19922997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reversal of resistance to adriamycin in human breast cancer cell line MCF-7/ADM by silencing AEG-1 gene and its mechanism].
    Yuan L; Shi RR; Rao SM; Song JL; Cui MC
    Sheng Li Xue Bao; 2014 Oct; 66(5):625-30. PubMed ID: 25332010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts.
    Gupta AK; Gupta M; Yarwood SJ; Curtis AS
    J Control Release; 2004 Mar; 95(2):197-207. PubMed ID: 14980768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticles.
    Unsoy G; Gunduz U
    Expert Rev Anticancer Ther; 2016 Jul; 16(7):789-97. PubMed ID: 27130312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
    Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
    Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.